Doctors are aiming radiation beams at arthritic knees, and the results suggest this unorthodox approach might spare some patients from pills or surgery. A randomized trial in South Korea found that a single course of low-dose radiation therapy reduced pain and improved function in people with mild to moderate knee osteoarthritis, offering what researchers call a “moderate intervention” between medications and joint replacement.
The treatment sounds alarming at first. Radiation for a bad knee? But the doses involved are tiny. Patients received just 3 gray units of radiation over six sessions, less than 5% of what’s used in cancer treatment. The radiation targets joints positioned away from vital organs, and researchers reported zero side effects related to the therapy itself.
What makes this study unusual is its placebo control group. In a field notorious for strong placebo responses, 114 participants were randomly assigned to receive either a very low dose (0.3 Gy), a low dose (3 Gy), or simulated treatment where the machine was turned on but delivered nothing. Nobody knew which group they were in.
The Numbers Tell the Story
After four months, 70% of patients receiving the 3 Gy dose met criteria for meaningful improvement in pain, physical function, or overall condition. The placebo group wasn’t far behind at 42%, but the difference was statistically significant. The ultra-low 0.3 Gy dose performed no better than fake treatment, suggesting there’s a threshold effect at work.
There’s a clinical need for moderate interventions between weak pain medications and aggressive surgery, and we think radiation may be a suitable option for those patients especially when drugs and injections are poorly tolerated.
Byoung Hyuck Kim, the trial’s principal investigator and assistant professor at Seoul National University College of Medicine, presented the findings at the American Society for Radiation Oncology’s annual meeting in San Francisco. He emphasized that the study design minimized confounding factors. Participants were restricted to acetaminophen for pain relief during the four-month follow-up period, no stronger drugs allowed.
That restriction matters. Previous studies permitted NSAIDs or opioids, which could mask radiation’s effects. By keeping analgesics minimal, the Korean team could more confidently attribute improvements to the radiation itself rather than pharmaceutical interventions.
Old Treatment, New Evidence
Low-dose radiation for joint pain is standard practice in Germany and Spain, but it remains largely unknown to American physicians. Kim attributes this to misconceptions about therapeutic radiation and a lack of high-quality placebo-controlled evidence, which this trial now provides.
The substantial placebo response—42% of sham-treated patients improved—initially surprised researchers but aligns with rates seen in other osteoarthritis trials testing injections or medications. Kim noted this underscores why rigorous placebo controls are essential in arthritis research, where expectations and natural disease fluctuations can muddy results.
For severe osteoarthritis, where the joint is physically destroyed and cartilage is already gone, radiation will not regenerate tissue. But for people with mild to moderate disease, this approach could delay the need for joint replacement.
The treatment appears best suited for patients whose joints retain some structure and show signs of inflammation. It won’t rebuild destroyed cartilage or reverse severe degeneration, but it might buy time for the 32.5 million American adults living with osteoarthritis, particularly those who can’t tolerate pain medications or want to postpone surgery.
The research team is now tracking patients through 12 months to see if benefits persist and correlating symptom relief with imaging changes in joint structure. Future studies will examine which patient subgroups respond best and whether combining radiation with physical therapy or weight loss produces even stronger results. Economic analyses comparing radiation to injections and medication regimens are also planned.
For now, Kim suggests low-dose radiation should enter discussions alongside weight loss, physiotherapy, and medications as part of shared decision-making. The approach won’t suit everyone, but for patients stuck between ineffective pills and invasive surgery, a few sessions under a radiation beam might offer an unexpected middle path.
International Journal of Radiation Oncology, Biology, Physics: 10.1016/j.ijrobp.2025.07.2342
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.